BioCentury
ARTICLE | Clinical News

Idenix preclinical data

April 7, 2014 7:00 AM UTC

In HCV cell-based assays, IDX21437 selectively inhibited HCV replicons. Idenix also said the compound was active against HCV NS5B genotypes 1-6, but not against human polymerases. Data will be present...